Biosurgery Market: Global Trends, Top Players Updates, Future Plans, Industry Impact and Forecast till 2027
UnivDatos Market Insights (UMI)
Knowledge Delivered Intelligently
In various surgeries, biosurgery products are utilized to reduce intra- and post-operative problems. The inefficient use of standard wound closure materials, such as sutures and staples, is one of the leading causes of blood loss in surgical and trauma patients. The rising frequency of accidents around the world has resulted in an increase in the number of procedures requiring extensive operating hours. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed. As per an article published by National Library of Medicine, in 2019, uncontrolled hemorrhage is the leading cause of preventable death that occurs due to injury. Similarly, as per National Trauma Institute, after a traumatic injury, hemorrhage is responsible for over 35% of pre-hospital deaths and over 40% of deaths within the first 24 hours of the injury. The number of surgeries that involve long operating times is increasing. In such a scenario, there is a growing demand for effective blood loss management products.?
Furthermore, High prevalence of diabetes and spinal injuries is anticipated to propel the demand for biosurgery in the forthcoming years. For instance, in 2019, diabetes was estimated to affect 463 million people worldwide, accounting for 9.3% of the adult population aged 20 to 79 years. By 2030, this number is predicted to rise to 578 million (10.2 percent) and 700 million (10.9 percent) by 2045. In 2019, the prevalence of diabetes was expected to be 9.0 percent in women and 9.6 percent in men. In addition, as per World Health Organization (WHO), it’s believed that there are between 250,000 and 500,000 new spinal cord injuries every year.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=4770 ?
The spread of COVID-19 around the world with over 4.5 million cases and over 300,000 deaths in 2020 has brought new challenges for the international medical and surgical community. Every specialty has had to adjust to the urgency of their daily surgical procedures and, where possible, pursue non-surgical therapy methods. To deliver critical emergency surgery, surgeons had to adopt new guidelines. The United Kingdom (UK) has a low critical care bed capacity when compared to other European countries. For instance, as per a paper by International Journal of Surgery in 2020, a comparison between the UK and Germany showed a difference in Intensive Care Unit (ICU) bed numbers of 7.5 versus 31.8 per 100,000 population, respectively. Moreover, as per Imperial College COVID-19 Response a critical care bed demand of more than 30 times the UK capacity. Due to this the surgical facilities have been utilized to handle the crisis. This also expected to have a significant backlog of future patient demand, even if some of the deferred cases are never rescheduled. This had an adverse effect on the biosurgery market. ?
According to UnivDatos Market Insights (UMI)’ research report “Global Biosurgery Market Analysis, 2020”, the Global Biosurgery market is projected to grow at a CAGR of XX% during 2021-27F. The increased advancements in surgeries and novel product launch to help surgeons perform surgeries efficiently are the prominent reasons which is driving the market of the Biosurgery. For Instance: As per Eurostats, in 2018, caesarian procedure was performed at least 1.16 million times in the EU. A total of 233 300 caesarean sections were performed in Germany, while 146,200 to 151,100 were performed in Poland, France, and Italy, also the high number of caesarean sections of about 685,500 were performed in Turkey (685, 500) in 2018.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=4770 ?
Based on the product, bone graft attachments grabbed XX% revenue share in 2020. The market size of this segment touched US$ XX Million in 2020. The market share of the segment is expected to maintain its dominance in the forthcoming years as well owing to the increasing use of bone graft substitute products in orthopedic and dental surgeries and significant benefits offered by bone graft substitute products over conventional autograft products.?
Based on the Application, the Orthopedics surgery segment acquired the major market share and grabbed US$ XX Million revenues from the Biosurgery market in 2020. Increasing prevalence of bone diseases, and cases of road accidents is boosting the growth. Every year, over 900,000 procedures in the United States require bone replacement or repair, according to the Medicare and Medicaid program. However, cardiovascular surgery is expected to grow at a fast pace during the forecast period owing to the prevalence of diabetes and heart disease.
Orthopedics Surgery to Witness Robust growth?
Based on the end-user, hospitals grabbed XX% revenue share in 2020. The market size of this segment touched US$ XX Million in 2020. The market share of the segment is expected to maintain its dominance in the forthcoming years as well owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.?
North America to Grab Lion’s Share, Bit Europe to witness Explicit Growth
Based on the Region, North America dominated the Global Biosurgery market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the Advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, and high healthcare spending. For instance, according to the OECD data, the United States invested roughly 17.2 percent of its GDP in health care systems in June 2018.?
For more informative information, please visit us – https://univdatos.com/report/biosurgery-market-500/
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Global Biosurgery market are Johnson & Johnson (Ethicon), Medtronic Plc, Strykers, Baxter International Inc., C.R. Bard, Sanofi, Pfizer, B. Braun Melsungen AG, Integra Lifesciences Corporation, and Zimmer Biomet among others. The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry. Some of the instances are:
·???????In February 2020, Baxter announced 510 (k) clearance from US FDA for Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip. The product is a staple line reinforcing agent that is used to control bleeding during bariatric and other surgical procedures.
·???????In February 2020, Integra LifeSciences Holdings Corp. launched AmnioExcel Plus Placental Allograft Membrane for soft tissue repairing.
领英推荐
·???????In October 2020, Orthofix Medical Inc. (US) announced the launch of O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, a ready-to-use cervical and lumbar spacers for allograft procedures.
·???????In December 2019, Johnson & Johnson announced the launch of next generation sealant solution, VISTASEAL Fibrin Sealant (Human), this helps to control bleeding during surgery.
“Global Biosurgery Market Analysis , 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Biosurgery providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.???????
Market Segmentation:
1.?????By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, And Bone Graft Attachments)
2.?????By Application (Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurological Surgery, And Others (Reconstructive, Urology, And Gynecology Surgeries)
3.?????By End-User (Hospitals, Clinics, And Others)
4.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)
5.?????By Company (Johnson & Johnson (Ethicon), Medtronic Plc, Strykers, Baxter International Inc., C.R. Bard, Sanofi, Pfizer, B. Braun Melsungen AG, Integra Lifesciences Corporation, Zimmer Biomet, etc.)
Key questions answered in the study:
1.?????What are the current and future trends of the Global Biosurgery industry?
2.?????How the industry has been evolving in terms of technology and application areas?
3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?
4.?????What are the key growth drivers and challenges for the Biosurgery industry?
5.?????What is the customer orientation, purchase behavior, and expectations from the Biosurgery firms across various regions??